How Equity Grants to Advisors, Contractors, and Strategic Partners Quietly Pollute Your Cap Table Before Series B

Non-employee equity grants issued to advisors, contractors, and strategic partners outside a formal equity incentive plan represent real securities that directly impact fully diluted ownership. While founders frequently use these instruments to preserve cash early on, they carry rigid authorization, 409A valuation, intellectual property assignment, and corporate governance obligations that often go overlooked until institutional investors evaluate the company. Missing or informal documentation is treated by a Series B lead investor as a severe process and disclosure failure rather than a minor administrative paperwork gap. Because discovering invisible dilution, tax penalties, or unresolved IP ownership gaps mid-diligence can completely derail a financing round, executing a rigorous equity cleanup and preparing a centralized grant register before investor outreach is essential for institutional readiness.

The problem surfaces at Series B. When a lead investor models fully diluted ownership and finds advisor shares, contractor warrants, or partner equity that was issued informally, tracked in a side contract, or missing from cap table software entirely, the round does not move forward until those grants are explained, validated, and resolved. This is one of the most common cap table issues that can stop a Series B before the lead investor even reads your deck.

Key takeaways:

• Informal non-employee equity is not a minor admin issue. It is a financing-readiness liability.
• A Series B lead does not care what you called the grant. They care whether it was authorized, documented, valued, and disclosed.
• Missing documentation is treated as a disclosure failure, not a paperwork gap.
• Undocumented grants create four distinct problems: dilution ambiguity, 409A tax exposure, IP ownership gaps, and governance friction.
• Cleanup before outreach is almost always cheaper and faster than explaining problems mid-diligence.

What These Grants Actually Are, and Why Founders Issue Them Outside a Formal Plan

Founders issue equity to non-employees for practical reasons. An advisor brings industry relationships or technical credibility. A contractor builds core product infrastructure. A strategic partner opens a distribution channel. Cash is tight, so equity fills the gap.

The instruments vary, but the four most common types are:

• Advisor shares: Restricted stock awards (RSAs) or non-qualified stock options (NSOs) granted to individuals providing strategic guidance. Advisors cannot receive ISOs because incentive stock options are limited to employees under U.S. tax law.
• Contractor equity: NSOs or RSAs issued to developers, designers, or other service providers in lieu of or alongside cash compensation.
• Strategic partner warrants: Rights to purchase shares at a fixed price, often negotiated as part of a commercial or distribution agreement.
• Board observer equity: Shares or options bundled with observer rights or information rights granted to individuals who attend board meetings without voting authority.

The table below shows how each grant type typically behaves across the dimensions that matter most at Series B:

The Founder Institute FAST Agreement provides a standardized framework for advisor equity with defined engagement levels, a 3-month cliff, and roughly a 2-year vesting schedule. Grants that lack this structure are conspicuous by comparison. When a Series B lead sees an advisor grant with no vesting schedule, no cliff, and no signed agreement, the absence of structure is itself a signal.

Why These Grants Create Valuation and Dilution Problems at Series B

A Series B lead models fully diluted ownership before pricing the round. Non-employee grants that are undocumented, mispriced, or missing from cap table software break that model in three specific ways.

Problem 1: Invisible dilution

Grants issued outside a formal equity plan are often tracked in standalone contracts, email threads, or side letters rather than in equity management software. When a lead investor requests a fully diluted cap table, those shares are missing. The company's ownership percentages look cleaner than they are. When the grants surface during diligence, the investor must remodel the round from scratch, which delays pricing and raises questions about what else might be missing.

Problem 2: 409A pricing exposure

Section 409A of the Internal Revenue Code applies to all service providers, including contractors, advisors, and board members, not just employees. If a non-qualified stock option was granted at an exercise price below fair market value, it may be treated as deferred compensation subject to Section 409A. The consequence is immediate taxation upon vesting plus a 20% federal penalty tax on the affected amount, according to IRS Notice 2005-1 as analyzed by EisnerAmper. A Series B lead who finds mispriced contractor or advisor options must assess whether that tax exposure is the company's problem to remediate before close.

Problem 3: Unvested grants with no forfeiture mechanism

Carta's advisory shares guidance notes that RSA grants typically give the company a right to repurchase unvested shares if the advisor stops working with the company. If that repurchase right was never documented, the company cannot model how many shares will actually be outstanding at close. Investors price rounds on certainty. An unknown share count is not a minor rounding issue.

Why These Grants Create IP and Governance Problems Investors Will Not Ignore

Dilution is only part of the problem. Non-employee equity creates two additional categories of risk that a Series B lead will flag independently: IP ownership and agreement-level governance.

IP ownership gaps

When a contractor or strategic partner receives equity but never signs a formal IP assignment agreement, the company may not clearly own the work product that person created. This matters at Series B because investors are buying into the company's technology, product, and proprietary assets. If a contractor built a core feature and retained IP rights because no assignment was executed, the company has an ownership problem that cannot be solved by updating the cap table.

Governance and consent friction

Advisor and observer agreements sometimes include:

• Information rights that require sharing financial data with individuals who are not parties to the Series B
• Consent provisions that give the advisor approval rights over certain company actions
• Transfer restrictions that interact with the preferred stock terms being negotiated
• Confidentiality gaps that conflict with the investor's diligence process

Any of these provisions can create friction during a financing. A lead investor who discovers mid-diligence that an advisor holds consent rights over a board action required to close the round now has a structural problem, not just a documentation problem. If you want to understand how consent rights embedded in equity agreements can escalate into a full governance blockage, the breakdown of how investor consent rights can turn your cap table into a governance hostage situation applies the same logic at a deeper level.

The investor's view: An undocumented grant found during diligence is not treated as an oversight. It is treated as evidence that the company does not have complete knowledge of its own equity history. That inference extends to every other representation the company has made about its cap table and governance.

If you are raising a Series B and want to understand how non-employee equity fits into the broader question of how to raise capital for a startup, the answer is that equity hygiene is part of institutional readiness, not a separate legal task.

What Must Be Resolved Before You Approach a Series B Lead

There are four actions that must be completed before you contact a Series B lead. These are not optional cleanup items. They are the minimum standard for institutional diligence readiness.

Step 1: Build a complete non-employee equity register.

List every grant issued to an advisor, contractor, strategic partner, or board observer. For each grant, record the recipient name, grant date, instrument type, share count, exercise price, vesting schedule, forfeiture or repurchase terms, IP assignment status, board approval date, and the governing document reference. If any of these fields are blank, that is the problem you need to fix first.

Step 2: Confirm 409A compliance for every option or option-like grant.

Under SEC Rule 701, compensatory grants to advisors and consultants must be made under a written compensatory plan or contract. Separately, any NSO granted at a price below fair market value without a current 409A valuation may carry tax exposure for the recipient and remediation cost for the company. Confirm whether a valid 409A was in place at the time of each grant. Where it was not, assess the exposure with legal and tax counsel before outreach begins.

Step 3: Review every related agreement for rights that create financing friction.

Pull every advisor agreement, contractor agreement, and strategic partner contract. Review each one for information rights, consent provisions, observer rights, transfer restrictions, and confidentiality terms. Flag any provision that could require disclosure to a third party during the round, restrict a board action needed to close, or conflict with the preferred stock terms being negotiated.

Step 4: Choose the right resolution path for each grant.

For each outstanding grant, assess whether the cleanest fix is cancellation, buyback, re-documentation, or full disclosure with updated dilution modeling. This decision depends on the relationship status, documentation quality, and the specific rights attached to the grant.

Data room standard: Before outreach, prepare a short grant summary memo covering every non-employee grant, its current status, and the resolution taken or planned. Load the memo and supporting documents into the data room. Investors who find this memo already prepared treat it as a sign of process maturity. Those who have to ask for it do not.

If you are also working through how convertible instruments interact with your cap table, the SAFE and convertible note dilution analysis here covers the same investor-readiness standard applied to a different instrument type.

When Cancellation, Buyback, or Re-Documentation Is the Right Fix, and When Disclosure Is Enough

Not every informal grant requires the same resolution. The right path depends on three factors: whether the relationship is still active, whether the documentation is fixable, and whether the grant carries rights that create financing friction.

Choose cancellation or buyback when:

• The relationship has ended and the grant was never formally documented
• The grant contains consent rights, information rights, or transfer restrictions that would create friction during the round
• The recipient is willing to negotiate a clean exit from the equity relationship

Choose re-documentation when:

• The relationship is ongoing and the economics of the grant are reasonable
• The only problem is missing paperwork, unsigned agreements, or incomplete vesting schedules
• Board approval can be retroactively confirmed or properly documented with counsel

Choose disclosure and modeling when:

• The grant is validly documented, board-approved, and properly priced
• IP assignment is confirmed in writing
• No consent rights, information rights, or transfer restrictions conflict with the financing
• The dilution impact is small and already reflected in the fully diluted model

The real risk of doing nothing: Diligence escalates small inconsistencies into trust problems. A grant that looks minor to a founder looks like a process failure to an investor. The question is not whether the issue is large enough to matter. The question is whether the investor will feel confident that they have seen everything.

For a broader view of how debt and equity instruments interact in a capital stack before a major raise, the debt vs. equity financing guide for founders covers the structural tradeoffs relevant to this stage.

Pre-Series B Non-Employee Equity Cleanup Checklist

Use this checklist with your legal counsel and CFO before approaching any Series B lead.

• Inventory every advisor, contractor, strategic partner, and board observer grant or warrant
• Confirm board approval for each grant or identify where approval is missing
• Verify vesting schedules and forfeiture or repurchase rights are documented in writing
• Confirm IP assignment for every contractor and strategic partner who received equity
• Check that a current 409A valuation was in place at the time of each NSO grant
• Review every related agreement for information rights, consent provisions, observer rights, and transfer restrictions
• Enter all grants into cap table software and reconcile against the fully diluted share count
• Model dilution at the anticipated Series B price including all non-employee grants
• Prepare a grant summary memo for the data room covering status and resolution for each grant
• Load all governing documents, board consents, and IP assignments into the data room before outreach begins

Also review how stacked convertible instruments interact with this dilution picture. The analysis of how SAFEs and convertible notes stack up and silently destroy your Series B cap table addresses the same fully diluted modeling standard from a different angle.

Frequently Asked Questions

Do advisor shares count toward fully diluted shares at Series B?

Yes. Advisor shares count toward fully diluted ownership regardless of how they were issued or whether they appear in cap table software. A Series B lead calculates fully diluted ownership by including all outstanding shares, all vested and unvested options, all warrants, and any other contractual rights to acquire shares. Advisor shares that are missing from the cap table model create an ownership discrepancy that must be corrected before pricing.

How does a missing IP assignment affect a Series B diligence process?

A missing IP assignment means the company may not legally own the work product created by the contractor or partner who received equity. Investors conducting diligence will request IP assignment confirmations as a standard item. If an assignment is absent, the investor must assess whether the company's core assets are fully owned. That assessment can delay the round or require a cure agreement with the original contractor before close.

Does contractor equity issued without a current 409A create tax liability?

It can. Section 409A applies to all service providers, not just employees. If a non-qualified stock option was granted to a contractor at a price below fair market value on the grant date, the option may be treated as deferred compensation subject to Section 409A. The tax consequence falls on the recipient: immediate income recognition upon vesting plus a 20% federal penalty tax. A Series B lead will flag this exposure and expect the company to have assessed and documented the risk.

What happens to unvested advisor grants when a company raises a Series B?

Unvested advisor grants remain outstanding through a Series B unless the grant agreement includes acceleration provisions triggered by a financing event. Some advisor agreements include single-trigger acceleration, meaning all unvested shares vest immediately upon a defined event such as a new financing. If that clause exists and was not modeled into the fully diluted share count, the round closes with more shares outstanding than the investor expected.

How should non-employee equity be disclosed in a Series B data room?

Prepare a grant summary memo listing every non-employee grant with the recipient, instrument type, grant date, share count, exercise price, vesting status, IP assignment status, board approval reference, and governing document. Load the memo alongside the underlying agreements, board consents, and any 409A reports in the data room. Investors who find a complete and organized disclosure treat it as a positive signal. Investors who have to request it treat the absence as a gap.

Can advisor grants be cancelled or bought back before a Series B?

Yes, with the advisor's consent. Cancellation or buyback requires a written termination agreement signed by both parties. For RSA grants, the company may have a contractual repurchase right for unvested shares that can be exercised without the advisor's consent if the relationship has ended, depending on the original agreement. For NSOs, cancellation typically requires mutual agreement. Either path should be completed and documented before the data room opens.

What does a Series B lead look for when reviewing non-standard equity agreements?

A Series B lead reviewing non-standard equity agreements is looking for four things: valid authorization (was the grant properly approved?), correct pricing (was a current 409A in place?), clean IP (was work product formally assigned?), and clean rights (do the agreements contain consent, information, or transfer provisions that interact with the new financing?). Any one of these issues can require a cure before the round closes. All four together signal a process problem that extends beyond the specific grants.

Continue reading this series:

• The Capital Stack Explained: Equity, Debt, SAFEs, and What Investors Actually Want
• How to Value a Startup: Complete Valuation Guide for Founders
• How to Raise Capital in 2026 for Your Series A Round

IRC Partners advises founders raising $5M to $250M of institutional capital on structure, positioning, and round architecture. 7 strategic partners per quarter. No placement agent model. No success-only theater. If you want a structural review of your current raise, apply at HERE